SCHEMBL443030

SCHEMBL443030

CCO[Si](OCC)(OCC)C(CC)C(C)NC(=O)O

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.30
GAA P10253 1/20 0.30
SI P14410 1/20 0.30
MGAM2 Q2M2H8 1/20 0.30
MMP8 P22894 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9850953 0.84
SCHEMBL2145053 0.76 MGAM (0.33) MGAMGAASIMGAM2
SCHEMBL10754520 0.75
SCHEMBL8959216 0.73
SCHEMBL8813853 0.72 ALDH1A1 (0.36) MGAMGAASIMGAM2
SCHEMBL4637407 0.71 MGAM (0.30) MGAMGAASIMGAM2
Dimethylamine SCHEMBL28094804 0.69 TSHR (0.31)
SCHEMBL5809591 0.69
SCHEMBL27589740 0.69
SCHEMBL28334108 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3529815-B1 SOLID ELECTROLYTIC CAPACITOR COMPRISING A SILANE AGENT BETWEEN THE ANODE AND THE CONDUCTIVE POLYMER KYOCERA AVX COMPONENTS CORP (US) 2026-05-06 EP claimed
US-12268617-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2025-04-08 US claimed
US-20240189121-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2024-06-13 US claimed
EP-3666299-B1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP (US) 2024-05-15 EP claimed
US-11903850-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2024-02-20 US claimed
US-20230036800-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2023-02-02 US claimed
US-11406514-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2022-08-09 US claimed
US-11369497-B2 Anti-thrombogenic medical devices and methods COVIDIEN LP (US) 2022-06-28 US claimed
US-20210068991-A1 ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS COVIDIEN LP 2021-03-11 US claimed
US-10892095-B2 Solid electrolytic capacitor assembly AVX CORPORATION (US) 2021-01-12 US claimed
US-7374684-B2 Method of separating components in a sample using silane-treated silica filter media DOW CORNING CORPORATION (US) 2008-05-20 US claimed
US-20070267349-A1 METHOD OF SEPARATING COMPONENTS IN A SAMPLE USING SILANE-TREATED SILICA FILTER MEDIA DOW CORNING CORPORATION 2007-11-22 US claimed
EP-1838173-A2 METHOD OF PREVENTING OR REDUCING OFF-FLAVOR IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA DOW CORNING CORPORATION (US) 2007-10-03 EP claimed
EP-1737551-A2 METHOD OF SEPARATING COMPONENTS IN A SAMPLE USING SILANE-TREATED SILICA FILTER MEDIA GENENCOR INTERNATIONAL, INC. (US) 2007-01-03 EP claimed
EP-1737305-A2 METHOD OF PREVENTING OR REDUCING HAZE IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA GENENCOR INTERNATIONAL, INC. (US) 2007-01-03 EP claimed
WO-2006065556-A2 METHOD OF PREVENTING OR REDUCING OFF-FLAVOR IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA DOW CORNING CORPORATION (US) 2006-06-22 WO claimed
WO-2005117616-A9 METHOD OF PREVENTING OR REDUCING HAZE IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA GENENCOR INT (US) 2006-05-04 WO claimed
WO-2005117616-A2 METHOD OF PREVENTING OR REDUCING HAZE IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA GENENCOR INTERNATIONAL, INC. (US) 2005-12-15 WO claimed
WO-2005115580-A2 METHOD OF SEPARATING COMPONENTS IN A SAMPLE USING SILANE-TREATED SILICA FILTER MEDIA GENENCOR INTERNATIONAL, INC. (US) 2005-12-08 WO claimed
US-20050029195-A1 Method of separating components in a sample using silane-treated silica filter media DOW CORNING CORPORATION 2005-02-10 US claimed